GJA1 and prostate cancer: The data reported by Fukushima et al. [27] suggested Connexin 43 as a tumor suppressor gene and transfection of Connexin 43 cDNA into human prostate cancer PC-3 cells increased tumor cell sensitivity to Docetaxel.